Annual General Meeting of Kuros Biosciences approves all resolutionsSchlieren (Zurich), Switzerland, April 15, 2026 – Kuros Biosciences (“Kuros” ...
Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026 Financial Highlights Total ...
It’s time to say out loud: osteobiologics has been coasting for a decade. Not failing — coasting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results